Someone just asked a related question on the PRAN CC; the PRAN speaker said the decline rate from 12 weeks to 26 weeks was within normal bounds.
Also, someone asked why no benefit relative to placebo was seen in the Trailmaking Part A test; the answer was that the Part A test, which does not alternate between numbers and letters, is much less demanding than the Part B test, which does.